Raclopride studies of dopamine release: dependence on presynaptic integrity

This publication has 25 references indexed in Scilit:

• Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP‐treated monkeys: PET studies with [¹¹C]raclopride
  Synapse, 2002
• In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism
  Synapse, 2000
• Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with pet in nonhuman primates
  Synapse, 1998
• 6-[18F]fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys
  Synapse, 1998
• Kinetic Modeling of [¹¹C]Raclopride: Combined PET-Microdialysis Studies
  Journal of Cerebral Blood Flow & Metabolism, 1997
• Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
  Proceedings of the National Academy of Sciences, 1997
• Striatal binding of the PET ligand ¹¹C‐raclopride is altered by drugs that modify synaptic dopamine levels
  Synapse, 1993
• In vivo [³H]Spiperone Binding: Evidence for Accumulation in Corpus Striatum by Agonist-Mediated Receptor Internalization
  Journal of Cerebral Blood Flow & Metabolism, 1988
• Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study
  Journal of Neurochemistry, 1988
• Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
  Science, 1986